APPLICATIONS PUBLISHED 25 FEBRUARY 2004
Published: 1-Aug-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Closed loop drug administration method and apparatus using EEG complexity for control purposes
Instrumentarium Corp 1389953*
Control of compactability through crystallisation
Bristol-Myers Squibb 1390011*
Novel methods and compsns for delivering macromolecules to or via the respiratory tract
Nektar Therapeutics 1390012*
Therapeutic treatments using the direct application of antimicrobial metal compsns
Nucryst Pharmaceuticals 1390013*
Compsns and methods for treatment of hyperplasia
American Bioscience 1390014*
Taste-masking of highly water-soluble drugs
Cima Labs 1390015*
Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
Drexel University 1390016*
Reinforced matrices
Verigen Transplantation Services 1390017*
A pharmaceutical tablet having a high API content
Bristol-Myers Squibb 1390018*
Controlled release drug delivery device
Savit Consulting 1390019*
A coated film laminate having an ionic surface
£M Innovative Properties Co 1390020*
Delivery of compounds for the treatment of migraine through an inhalation route
Alexza Molecular Services 1390021*
Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno 2,3-D]pyrimidine for the treatment of pain
Arachnova Therapeutics 1390022*
Pharmaceutical salts
Gruenenthal 1390023*
Isostearic acid salts as permeation enhancers
Elan Corp 1390024*
Coenzyme Q and eicosapentaenoic acid (EPA)
Laxdale 1390025*
Treatment of HPV caused diseases
Cornell Research Foundation 1390026*
Compsn comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof
The Chinese University of Hong Kong 1390027*
Use of lipoic acid for suppressing haematological effects of chemotherapy and/or radiotherapy
NV Nutricia 1390028*
Phenylindones for the treatment of HIV
Idenix (Cayman); Universita Degli Studi di Cagliari 1390029*
Store operated calcium influx inhibitors and methods of use
Cellegy Pharmaceuticals 1390030*
Topical compsn containing a fungicide
Novartis Consumer Health 1390031*
Novel quaternary ammonium compsns coupled with facilitating anions and their use in kits, as well as their use in preventing and treating certain conditions
Bacaner, Marvin 1390032*
Farnesyl protein transferase inhibitors for treating cachexia
Janssen Pharmaceutica 1390033*
N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B-antagonists
Merck 1390034*
Method for treating ocular hypertension and glaucoma
Sucampo 1390035*
Prostanoic acid derivatives as agents for lowering intraocular pressure
Allergan 1390036*
Methods for treating delirium using glucocorticoid receptor-specific antagonists
Corcept Therapeutics 1390037*
Treatment of conditions relating to hormone deficiencies by administration of progestins
Endeavor Pharmaceuticals 1390038*
Use of oestrogen compounds to increase libido in women
Pantarhei Bioscience 1390039*
Pharmaceutical compsn for use in hormone replacement therapy
Pantarhei Bioscience 1390040*
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
Pantarhei Biosciences 1390041*
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
Pantarhei Biosciences 1390042*
Means and method for hormonal contraception
Pantarhei Biosciences 1390043*
Injectable pamidronate disodium
Sicor 1390044*
The use of a compound with a negatively charged domain of radicals
Bioneris 1390045*
Treatment of neoplasms with viruses
Wellstat Biologics 1390046*
Taste masking pharmaceutical compsn
Pacific Pharmaceuticals 1390047*
Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment of circulatory disorders
Shimizu Pharmaceutical; BioSeranTach 1390048*
Compsns for treating animal diseases and syndromes
Ramaekers, Joseph D 1390049*
Compsn for oral or corporeal hygiene or for health comprising seeds or ground material or protein extracts based on seeds of a plant of the genus moringa
Thurot, Phillipe 1390050*
Food compsns for reducing insulin resistance
Unilever 1390051*
Inhibition of JUN kinase
President and Fellows of Harvard College; The Regents of the University of California 1390052*
HCG formulation
Acevado, Hernan 1390053*
Mu-conopeptides
The University of Utah Research Foundation; Cognetix 1390054*
Tripeptide derivatives for the treatment of postlesional diseases of the nervous system
Neurotell 1390055*
Glycopeptide antibiotics
Wyeth Holdings 1390056*
Novel antipeptides that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use
Curagen Corp 1390057*
MRP8.MRP14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound healing substances
Switch Biotech Aktiengesellschaft 1390058*
Improved neuronal gene transfer
Centre National de la Recherche Scientifique 1390059*
Use of LP82 to treat body weight disorders
Eli Lilly 1390060*
Chronic treatment regimen using glucagon-like insulinotropic peptides
Eli Lilly 1390061*
Modulators of elastane inhibitor secretion
Centre for Blood Research 1390062*
Pharmaceutical dosage form of amorphous nelfinavir mesylate
F Hoffmann-La Roche 1390063*
Method of treating malignancies through induction of blood immune responses
Baylor Research Institute 1390064*
Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its B subunit
Duotol 1390065*
Vaccine compsn
GlaxoSmithKline Biologicals 1390066*
Compsns for use in treating IGE-associated disorders
Novartis 1390067*
Methods and formulations of using A1 adenosine and P2X purinoreceptor antagonists
Endacea 1390068*
Endopeptidase/anti-PSMA antibody fusion proteins for treatment of cancer
Cornell Research Foundation 1390069*
Use of IL-18 inhibitors for treating or preventing CNS injuries
Ares Trading 1390070*
Symbiotic regenerative agent
Schuer, Joerg 1390071*
Use of an AMPA receptor potentiator for the manufacture of a medicament for the treatment of type II diabetes
Eli Lilly 1390072*
Compsns having enhanced pharmacokinetic characteristics
Allergan 1390073*
Novel compsns and uses therefor
The University of Queensland 1390074*
Chemotherapeutic induction of EGR-1 promoter activity
The University of Chicago 1390075*
Maturation of antigen-presenting cells using activating T-cells
Xcyte Therapies 1390076*
Treatment and diagnosis of macrophage mediated disease
Purdue Research Foundation 1390077*
CT scanner for imaging a preselected portion of a patient
Analogic Corp 1390078*
Paramagnetic metal ion-based macrocyclic contrast agents
Board of Regents University of Texas System 1390079*
Azo compounds for type I phototherapy
Mallinckrodt 1390080*
Therapeutic and diagnostic compounds, compsns and methods
Neorx 1390081*
Novel retinoid derivatives and methods for producing said compounds and an anti-cancer pharmaceutical compsn comprising said compounds
Chebigen 1390343*
Organic compounds
Novartis 1390344*
Polythiourea lipid derivatives
Gencell 1390345*
Pyrrolidine ester derivatives with oxytocin modulating activity
Applied Research Systems 1390347*
5-cyano-1H-indole derivatives as antagonists of the interleukine-8 receptors
Laboratoires Fournier 1390348*
Aminoquinoline and aminopyridine derivatives and their use as adenosine ligands
Sanofi-Synthelabo 1390349*
Novel compounds
AstraZeneca 1390350*
Pyrimidine derivatives useful as selective COX-2 inhibitors
Glaxo Group 1390351*
Pyrimidine derivatives
Glaxo Group 1390352*
Triazole-derives kinase inhibitors and uses thereof
Vertex Pharmaceuticals 1390353*
Triazinyl acrylamide derivatives as kinase inhibitors
Amgen 1390354*
New crystal forms of lamotrigine and processes for their preparations
Teva Pharmaceutical 1390355*
Arylisoxazoline derivatives, method for production and use thereof as pesticides
Bayer CropScience 1390356*
Anti-thrombotic compounds, production and use thereof as medicaments
Boehringer Ingelheim 1390357*
Amino acid derivatives of triptolide compounds as immune modulators and anticancer agent
Pharmagenesis 1390358*
Synthesis of cannabinoids
Johnson Matthey 1390359*
Crystalline form of omeprazole
Lek Pharmaceuticals 1390360*
Melanocortin receptor ligands
Procter & Gamble 1390361*
Substituted benzofurans and benzothiophenes, method of making and methods of use as integrin antagonists
3-Dimensional Pharmaceuticals 1390362*
Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
Bristol-Myers Squibb 1390363*
Aryl-8-azabicyclo 3.2.1]octanes for the treatment of depression
Wyeth 1390364*
Novel sulphonamate substituted pyrazol pyridine derivatives
Bayer HealthCare 1390365*
The citrate salt of 5,8,14-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentane
Pfizer Products 1390366*
Dihydroimidazo 5,1-A]-(b)-carboline derivatives, method for preparing same and use thereof as medicine
Macef 1390367*
Disubstituted 7,9-guaninium halides as telomerase inhibitors
Pharmacia Italia 1390368*
4-amino-5-phenyl-7-cycloburyl-pyrrolo(2,3-D)pyrimidine derivatives
Novartis 1390369*
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
Immunogen 1390370*
Oxazolo- and furaopyrimidines and their use as medicaments against tumours
Novartis 1390371*
1-oxa-3,9-diaza-spiro'5,5]undecan-2-ones derivatives and its use as antagonist of the neurokinin receptor
F Hoffmann-la Roche 1390372*
Process for the preparation of 4-amino-1-hydroxybutylidene-1,1-biphosphonic acid
EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Te Ti Caret 1390373*
